Christopher R. Bolen

3.6k total citations · 1 hit paper
54 papers, 1.9k citations indexed

About

Christopher R. Bolen is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Christopher R. Bolen has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pathology and Forensic Medicine, 23 papers in Oncology and 15 papers in Immunology. Recurrent topics in Christopher R. Bolen's work include Lymphoma Diagnosis and Treatment (31 papers), CAR-T cell therapy research (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Christopher R. Bolen is often cited by papers focused on Lymphoma Diagnosis and Treatment (31 papers), CAR-T cell therapy research (11 papers) and Chronic Lymphocytic Leukemia Research (8 papers). Christopher R. Bolen collaborates with scholars based in United States, Switzerland and Canada. Christopher R. Bolen's co-authors include Steven H. Kleinstein, Michael D. Robek, Gur Yaari, Siyuan Ding, Juilee Thakar, Mark M. Davis, Laurie H. Sehn, Tina Nielsen, Marek Trněný and Cornelia L. Dekker and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Christopher R. Bolen

52 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states

2017 305 citations David Furman, Junlei Chang et al. Nature Medicine profile →

Peers

Countries citing papers authored by Christopher R. Bolen

Since Specialization

Citations

This map shows the geographic impact of Christopher R. Bolen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Bolen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Bolen more than expected).

Fields of papers citing papers by Christopher R. Bolen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Bolen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Bolen. The network helps show where Christopher R. Bolen may publish in the future.

Co-authorship network of co-authors of Christopher R. Bolen

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Bolen. A scholar is included among the top collaborators of Christopher R. Bolen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Bolen. Christopher R. Bolen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas 2023 ·Blood ·Stephen J. Schuster, Ling‐Yuh Huw, Christopher R. Bolen, Victor Maximov, Andrew G. Polson, Katerina Hatzi, Elisabeth A. Lasater, Sarit Assouline, Nancy L. Bartlett, Lihua E. Budde, Matthew J. Matasar, Hartmut Koeppen, Emily Piccione, (unknown), Michael C. Wei, Shen Yin, Elicia Penuel	34
2	Novel CD20 Mutations As a Mechanism of Resistance to CD20-CD3 Targeted Therapies in Non-Hodgkin's Lymphoma 2023 ·Blood ·Victor Maximov, Christopher R. Bolen, Andrew G. Polson, Elicia Penuel, Elisabeth A. Lasater	1
3	A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA 2022 ·SHILAP Revista de lepidopterología ·Lale Kostakoğlu, F Dalmasso, Paola Berchialla, Larry A. Pierce, Umberto Vitolo, Maurizio Martelli, Laurie H. Sehn, Marek Trněný, Tina Nielsen, Christopher R. Bolen, Deniz Şahin, Calvin Lee, Tarec Christoffer El‐Galaly, Federico Mattiello, Paul E. Kinahan, Stéphane Chauvie	14
4	Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study 2021 ·Haematologica ·Lale Kostakoglu, Federico Mattiello, Maurizio Martelli, Laurie H. Sehn, David Belada, Chiara Ghiggi, Neil Chua, Eva González‐Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Christopher R. Bolen, Andrea Knapp, Gila Sellam, Tina Nielsen, Deniz Şahin, Umberto Vitolo, Marek Trněný	37
5	Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With Outcomes 2021 ·Frontiers in Oncology ·Hussein A. Abbas, Vakul Mohanty, (unknown), Yuefan Huang, Shaoheng Liang, Feng Wang, Jianhua Zhang, Yihua Qiu, Chenyue W. Hu, Amina A. Qutub, Monique Dail, Christopher R. Bolen, Naval Daver, Marina Konopleva, P. Andrew Futreal, Ken Chen, Linghua Wang, Steven M. Kornblau	9
6	Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy 2019 ·Clinical Cancer Research ·Magdalena Klánová, Mikkel Z. Oestergaard, Marek Trněný, Wolfgang Hiddemann, Robert Marcus, Laurie H. Sehn, Umberto Vitolo, Alexandra Bazeos, Valentin Goede, Harald Zeuner, Andrea Knapp, Deniz Şahin, (unknown), Christopher R. Bolen, Andrés F. Cardona, Christian Klein, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle‐Rowson	54
7	Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab 2019 ·Clinical Cancer Research ·Omid Hamid, Luciana Molinero, Christopher R. Bolen, Jeffrey A. Sosman, Eva Muñoz‐Couselo, Harriet M. Kluger, David F. McDermott, John D. Powderly, Indrani Sarkar, Marcus Ballinger, Marcella Fassò, Carol O’Hear, Daniel S. Chen, Priti S. Hegde, F. Stephen Hodi	58
8	Gene set meta-analysis with Quantitative Set Analysis for Gene Expression (QuSAGE) 2019 ·PLoS Computational Biology ·Hailong Meng, Gur Yaari, Christopher R. Bolen, (unknown), Steven H. Kleinstein	12
9	Increased T Cell Differentiation and Cytolytic Function in Bangladeshi Compared to American Children 2019 ·Frontiers in Immunology ·Lisa E. Wagar, Christopher R. Bolen, Natalia Sigal, Cesar J. Lopez Angel, Leying Guan, Beth D. Kirkpatrick, Rashidul Haque, Robert Tibshirani, Julie Parsonnet, William A. Petri, Mark M. Davis	12
10	Quantitative Comparison of Conventional and t-SNE-guided Gating Analyses 2019 ·Frontiers in Immunology ·Shadi Toghi Eshghi, Amelia Au‐Yeung, Chikara Takahashi, Christopher R. Bolen, (unknown), (unknown), Cherie Green, (unknown), William O’Gorman	52
11	Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing 2017 ·The Journal of Immunology ·Jason A. Vander Heiden, Panos Stathopoulos, Julian Q. Zhou, Luan Chen, Tamara J. Gilbert, Christopher R. Bolen, Richard J. Barohn, Mazen M. Dimachkie, Emma Ciafaloni, Teresa J. Broering, François Vigneault, Richard J. Nowak, Steven H. Kleinstein, Kevin C. O’Connor	75
12	The Repertoire Dissimilarity Index as a method to compare lymphocyte receptor repertoires 2017 ·BMC Bioinformatics ·Christopher R. Bolen, Florian Rubelt, Jason A. Vander Heiden, Mark M. Davis	37
13	Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states breakdown → 2017 ·Nature Medicine ·David Furman, Junlei Chang, Lydia Lartigue, Christopher R. Bolen, François Haddad, Brice Gaudillière, Edward A. Ganio, Gabriela K. Fragiadakis, Matthew H. Spitzer, Isabelle Douchet, Sophie Daburon, Jean‐François Moreau, Garry P. Nolan, Patrick Blanco, Julie Déchanet‐Merville, Cornelia L. Dekker, Vladimir Jojic, Calvin J. Kuo, Mark M. Davis, Benjamin Faustin	305
14	Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells 2016 ·Nature Communications ·Florian Rubelt, Christopher R. Bolen, Helen M. McGuire, Jason A. Vander Heiden, Daniel Gadala-Maria, Mikhail K. Levin, Ghia Euskirchen, Murad R. Mamedov, Gary E. Swan, Cornelia L. Dekker, Lindsay G. Cowell, Steven H. Kleinstein, Mark M. Davis	93
15	Quantitative gene set analysis generalized for repeated measures, confounder adjustment, and continuous covariates 2015 ·BMC Bioinformatics ·Jacob Turner, Christopher R. Bolen, Derek Blankenship	8
16	Systems Immunology Reveals Markers of Susceptibility to West Nile Virus Infection 2014 ·Clinical and Vaccine Immunology ·Feng Qian, Gautam Goel, Hailong Meng, Xiaomei Wang, Fuping You, Lesley Devine, Khadir Raddassi, Melissa N. Garcia, Kristy O. Murray, Christopher R. Bolen, Renaud Gaujoux, Shai S. Shen-Orr, David A. Hafler, Erol Fikrig, Ramnik J. Xavier, Steven H. Kleinstein, Ruth R. Montgomery	28
17	Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression 2013 ·Hepatology ·Christopher R. Bolen, Siyuan Ding, Michael D. Robek, Steven H. Kleinstein	153
18	Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations 2013 ·Nucleic Acids Research ·Gur Yaari, Christopher R. Bolen, Juilee Thakar, Steven H. Kleinstein	143
19	The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response 2012 ·Journal of Interferon & Cytokine Research ·Christopher R. Bolen, Michael D. Robek, Leonid Brodsky, Vincent Schulz, Joseph K. Lim, Milton W. Taylor, Steven H. Kleinstein	35
20	Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities 2010 ·Virology ·(unknown), (unknown), Christopher R. Bolen, Steven H. Kleinstein, Michael D. Robek	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact